Mutations analysis of STK11 gene in Chinese families with Peutz-Jeghers syndrome

2003 ◽  
Vol 48 (4) ◽  
pp. 333 ◽  
Author(s):  
Lianchun KANG
2011 ◽  
Vol 12 (1) ◽  
Author(s):  
Zhiqing Wang ◽  
Yulan Chen ◽  
Baoping Wu ◽  
Haoxuan Zheng ◽  
Jiman He ◽  
...  

2013 ◽  
Vol 58 (10) ◽  
pp. 2868-2872 ◽  
Author(s):  
BiXia Zheng ◽  
Jian Pan ◽  
Yaping Wang ◽  
Mei Li ◽  
Min Lian ◽  
...  

2015 ◽  
Vol 15 (1) ◽  
Author(s):  
Zhiheng Huang ◽  
Shijian Miao ◽  
Lin Wang ◽  
Ping Zhang ◽  
Bingbing Wu ◽  
...  

2015 ◽  
Vol 14 (3) ◽  
pp. 455-461 ◽  
Author(s):  
Pawel Borun ◽  
Marina De Rosa ◽  
Boguslaw Nedoszytko ◽  
Jaroslaw Walkowiak ◽  
Andrzej Plawski

Oncology ◽  
2004 ◽  
Vol 67 (5-6) ◽  
pp. 476-479 ◽  
Author(s):  
Chikashi Nakanishi ◽  
Tatsuro Yamaguchi ◽  
Takeru Iijima ◽  
Shigehira Saji ◽  
Masakazu Toi ◽  
...  

2009 ◽  
Vol 55 (4) ◽  
pp. 1032-1036 ◽  
Author(s):  
Ying Gao ◽  
Fa-Ming Zhang ◽  
Shu Huang ◽  
Xiang Wang ◽  
Ping Zhang ◽  
...  

2015 ◽  
Vol 23 (2) ◽  
pp. 332 ◽  
Author(s):  
Xu-Yan Mao ◽  
Ya-Fei Zhang ◽  
Gao-Ping Mao ◽  
Hai-Feng Wang ◽  
Shou-Bin Ning

Genetika ◽  
2017 ◽  
Vol 49 (2) ◽  
pp. 399-413
Author(s):  
Georgi Antov ◽  
Maria Krasteva ◽  
Silvia Andonova ◽  
Alexey Savov ◽  
Svetla Angelova ◽  
...  

Germline mutations affecting STK11 (LRG_319) are profoundly studied in relation to Peutz-Jeghers syndrome, predisposing to the development of various cancers at multiple sites. Though somatic mutations in STK11 are found to be present in several cancers, limited data on its involvement in sporadic breast cancer are available. The present study aims to evaluate the frequency and spectrum of genetic alterations in STK11 in a group of Bulgarian patients with sporadic breast cancer. A total of 73 tumor and 22 corresponding blood specimens derived from the patients, and 10 blood samples from clinically healthy controls were analyzed. High Resolution Melting analysis followed by Sanger sequencing and bioinformatic prediction tools were utilized. Seven patients (9.58%) harbored STK11 alterations, only two (2.74%) of which are exonic: one nonsense c.322A>T; p.K108X (deleterious) and one missense c.440G>A; p.Arg147His (of unknown significance). Two intronic variants were also observed: c.290+36G>T and c. *16+18C>A (novel). To our knowledge the results represent the first data indicating presence of STK11 alterations in patients with sporadic breast cancer. The limited number of the detected deleterious mutations indicates that mutational inactivation of the gene is a rare event and probably plays a minor role in sporadic breast carcinogenesis.


2020 ◽  
Vol 21 (21) ◽  
pp. 8201
Author(s):  
Andrea Cerasuolo ◽  
Francesca Cammarota ◽  
Francesca Duraturo ◽  
Annamaria Staiano ◽  
Massimo Martinelli ◽  
...  

Peutz–Jeghers Syndrome (PJS) is an autosomal dominant pre-cancerous disorder caused in 80–90% of cases by germline mutations in the tumor suppressor gene STK11. We performed a genetic test of the STK11 gene in two Italian young sisters suspected of PJS, since they showed pathognomonic café au lait spots in absence of other symptoms and familiarity. Sequencing of all exons of STK11 gene and other 8 genes, suggested to be involved in hamartomatous syndromes, (PTEN, BMPR1A, SDHB, SDHD, SMAD4, AKT1, ENG, PIK3CA) led to the identification in both the probands of a novel germline silent mutation named c.597 G>A, hitting the last nucleotide of exon 4. Interestingly, genetic testing of the two probands’ parents showed that their unaffected father was carrier of this mutation. Moreover, he carried a second intronic substitution named c.465-51 T>C (rs2075606) which was not inherited by his daughters. We also observed that all the family members carrying the c.597 G>A mutation presented an aberrant splice variant of STK11 mRNA lacking exon 4. Furthermore, in silico analysis of c.465-51 T>C substitution showed that it may activate an Enhancer Splicing Element. Finally, qRT-PCR analysis of STK11 expression levels showed a slight downregulation of the wild type allele in the father and a 2-fold downregulation in the probands compared to the unaffected mother. Our results have led the hypothesis that the c.465-51 T>C intronic variant, which segregates with the wild type allele, could increase the splicing effectiveness of STK11 wild-type allele and compensate the side effect of the c.597 G>A splicing mutation, being responsible for the phenotypic variability observed within this family. This finding highlight the importance of RNA analysis in genetic testing, remarking that silent DNA variant can often be splicing variant involved in disease onset and progression. The identification of these variants has a crucial role to ensure an appropriate follow-up and cancer prevention in at-risk individuals.


Sign in / Sign up

Export Citation Format

Share Document